Wellness Monitoring for Major Depressive Disorder

NCT02934334 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-11-04

No results posted yet for this study

Summary

The Wellness Monitoring for Major Depressive Disorder (MDD) study is a prospective, longitudinal, observational study aimed at identifying biomarkers of relapse in MDD. Results may help refine clinical approach to relapse management, and may ultimately help MDD patients sustain wellness while on antidepressant medication.

Conditions

Interventions

OTHER

Observational

Sponsors & Collaborators

  • Sidney Kennedy

    lead OTHER

Principal Investigators

  • Sidney H. Kennedy, MD · University Health Network, Toronto

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2019-01-14
Completion
2019-02-25

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02934334 on ClinicalTrials.gov